• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘脂类和溶酶体贮积症中的神经元变性。

Sphingolipids and neuronal degeneration in lysosomal storage disorders.

机构信息

Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.

出版信息

J Neurochem. 2019 Mar;148(5):600-611. doi: 10.1111/jnc.14540. Epub 2018 Aug 16.

DOI:10.1111/jnc.14540
PMID:29959861
Abstract

Ceramide, sphingomyelin, and glycosphingolipids (both neutral and acidic) are characterized by the presence in the lipid moiety of an aliphatic base known as sphingosine. Altogether, they are called sphingolipids and are particularly abundant in neuronal plasma membranes, where, via interactions with the other membrane lipids and membrane proteins, they play a specific role in modulating the cell signaling processes. The metabolic pathways determining the plasma membrane sphingolipid composition are thus the key point for functional changes of the cell properties. Unnatural changes of the neuronal properties are observed in sphingolipidoses, lysosomal storage diseases occurring when a lysosomal sphingolipid hydrolase is not working, leading to the accumulation of the substrate and to its distribution to all the cell membranes interacting with lysosomes. Moreover, secondary accumulation of sphingolipids is a common trait of other lysosomal storage diseases. This article is part of the Special Issue "Lysosomal Storage Disorders".

摘要

神经酰胺、鞘磷脂和糖脂(中性和酸性)的特点是在脂质部分存在一种称为神经鞘氨醇的脂族碱基。它们统称为鞘脂,在神经元质膜中特别丰富,通过与其他膜脂和膜蛋白相互作用,它们在调节细胞信号转导过程中发挥特定作用。因此,决定质膜鞘脂组成的代谢途径是细胞特性功能变化的关键点。在溶酶体贮积病中观察到神经元特性的异常变化,当溶酶体鞘脂水解酶不能正常工作时,就会发生溶酶体贮积病,导致底物积累,并分布到所有与溶酶体相互作用的细胞膜上。此外,鞘脂的继发性积累是其他溶酶体贮积病的共同特征。本文是“溶酶体贮积症特刊”的一部分。

相似文献

1
Sphingolipids and neuronal degeneration in lysosomal storage disorders.鞘脂类和溶酶体贮积症中的神经元变性。
J Neurochem. 2019 Mar;148(5):600-611. doi: 10.1111/jnc.14540. Epub 2018 Aug 16.
2
Characterization of mutants as a model for lysosomal sphingolipid storage diseases.将突变体表征为溶酶体鞘脂贮积病的模型。
Dis Model Mech. 2017 Jun 1;10(6):737-750. doi: 10.1242/dmm.027953. Epub 2017 Apr 7.
3
Sphingolipids and lysosomal pathologies.鞘脂与溶酶体疾病。
Biochim Biophys Acta. 2014 May;1841(5):799-810. doi: 10.1016/j.bbalip.2013.10.015. Epub 2013 Oct 31.
4
The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann-Pick disease type C.鞘脂类溶酶体贮积症的不断扩大的边界;来自尼曼-匹克病 C 型的见解。
Biochem Soc Trans. 2023 Oct 31;51(5):1777-1787. doi: 10.1042/BST20220711.
5
Neuronal sphingolipidoses: Membrane lipids and sphingolipid activator proteins regulate lysosomal sphingolipid catabolism.神经元鞘脂贮积症:膜脂和鞘脂激活蛋白调节溶酶体鞘脂分解代谢。
Biochimie. 2016 Nov;130:146-151. doi: 10.1016/j.biochi.2016.05.004. Epub 2016 May 5.
6
How membrane dysfunction influences neuronal survival pathways in sphingolipid storage disorders.膜功能障碍如何影响鞘脂贮积症中的神经元存活途径。
J Neurosci Res. 2016 Nov;94(11):1042-8. doi: 10.1002/jnr.23763.
7
My journey into the world of sphingolipids and sphingolipidoses.我在神经鞘脂类和神经鞘脂贮积症领域的探索之旅。
Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(10):554-82. doi: 10.2183/pjab.88.554.
8
Recent advances in the biochemistry of sphingolipidoses.鞘脂贮积症生物化学的最新进展
Brain Pathol. 1998 Jan;8(1):79-100. doi: 10.1111/j.1750-3639.1998.tb00138.x.
9
Pathology and current treatment of neurodegenerative sphingolipidoses.神经退行性鞘脂贮积症的病理学和现行治疗方法。
Neuromolecular Med. 2010 Dec;12(4):362-82. doi: 10.1007/s12017-010-8133-7. Epub 2010 Aug 22.
10
Sphingolipids and cell signalling.鞘脂与细胞信号传导。
J Inherit Metab Dis. 1998 Aug;21(5):472-80. doi: 10.1023/a:1005454602454.

引用本文的文献

1
Global and Targeted Metabolomics for Revealing Metabolomic Alteration in Niemann-Pick Disease Type C Model Cells.用于揭示尼曼-匹克病C型模型细胞中代谢组学改变的全局和靶向代谢组学
Metabolites. 2024 Sep 24;14(10):515. doi: 10.3390/metabo14100515.
2
Advancements in Engineering Planar Model Cell Membranes: Current Techniques, Applications, and Future Perspectives.工程平面模型细胞膜的进展:当前技术、应用及未来展望
Nanomaterials (Basel). 2024 Sep 13;14(18):1489. doi: 10.3390/nano14181489.
3
Serine Palmitoyltransferase (SPT)-related Neurodegenerative and Neurodevelopmental Disorders.
丝氨酸棕榈酰转移酶(SPT)相关的神经退行性和神经发育障碍。
J Neuromuscul Dis. 2024;11(4):735-747. doi: 10.3233/JND-240014.
4
Zebra-Sphinx: Modeling Sphingolipidoses in Zebrafish.斑马鱼模型:鞘脂贮积症研究。
Int J Mol Sci. 2023 Mar 1;24(5):4747. doi: 10.3390/ijms24054747.
5
Using BODIPY FL-Sphingolipid Analogs to Study Sphingolipid Metabolism in Mouse Embryonic Stem Cells.使用BODIPY FL鞘脂类似物研究小鼠胚胎干细胞中的鞘脂代谢。
Bio Protoc. 2022 Nov 20;12(22). doi: 10.21769/BioProtoc.4555.
6
Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).神经元神经节苷脂和糖鞘脂(GSL)代谢与疾病:继发性代谢错误级联可导致复杂的病理(在 LSDs 中)。
Adv Neurobiol. 2023;29:333-390. doi: 10.1007/978-3-031-12390-0_12.
7
Spectrum of Movement Disorders in Niemann-Pick Disease Type C.尼曼-匹克病 C 型的运动障碍谱。
Tremor Other Hyperkinet Mov (N Y). 2022 Sep 8;12:28. doi: 10.5334/tohm.701. eCollection 2022.
8
Sphingolipid metabolism and signaling in cardiovascular diseases.鞘脂代谢与心血管疾病中的信号传导
Front Cardiovasc Med. 2022 Aug 31;9:915961. doi: 10.3389/fcvm.2022.915961. eCollection 2022.
9
Application of Sygen in Diabetic Peripheral Neuropathies-A Review of Biological Interactions.Sygen在糖尿病周围神经病变中的应用——生物相互作用综述
Bioengineering (Basel). 2022 May 18;9(5):217. doi: 10.3390/bioengineering9050217.
10
Hydroxychloroquine Causes Early Inner Retinal Toxicity and Affects Autophagosome-Lysosomal Pathway and Sphingolipid Metabolism in the Retina.羟氯喹引起视网膜早期内层毒性,并影响视网膜的自噬溶酶体途径和神经酰胺代谢。
Mol Neurobiol. 2022 Jun;59(6):3873-3887. doi: 10.1007/s12035-022-02825-3. Epub 2022 Apr 15.